课题基金 / 基金详情

Roles of membrane-bound lectins in the regulation of immune cells.

Roles of membrane-bound lectins in the regulation of immune cells.
膜结合凝集素在免疫细胞调节中的作用。
批准号:
15390158
负责人:
TSUBATA Takeshi
金额:
$9.66万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2005

项目摘要

项目成果

TSUBATA Takeshi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
CD22 is a member of the siglec family and specifically recognizes a2,6 sialic acid, whereas CD72 contains a C-type lectin domain. These membrane-bound lectin molecules contain the immunoreceptor tyrosine-based inhibition motifs (ITIMs) in the cytoplasmic region. Upon phosphorylation, these ITIMs recruit and activate the SH2 domain containing tyrosine phosphatase 1 (SHP1), thereby down-regulate BCR signaling. We demonstrated that CD22-mediated signal regulation depends on the immunoglobulin isotypes of BCR. Indeed, CD22 negatively regulates signaling through IgM-BCR, IgD-BCR and IgA-BCR, but not signaling through IgG-BCR or IgE-BCR. In the absence of CD22-mediated signaling inhibition, IgG-BCR and IgE-BCR transmit augmented signaling, which may be involved in rapid antibody production in memory responses. The cytoplasmic regions of membrane form of IgG and IgE are involved in abrogation of CD22-mediated signal inhibition. In contrast, CD72 regulates BCR signaling regardless of Ig isotypes. SHP-1 contains two SH2 domains, and at least two out of tree ITIMs in CD22 are suggested to be essential for recruitment of SHP-1. We demonstrated that one ITIM is sufficient for recruitment of SHP-1 to CD22 and CD22-mediated signal regulation. Moreover, tyrosine at the position 783 locating in an ITIM appears to regulate phosporylation of other tyrosines in the cytoplamic region of CD22. These findings are crucial for elucidation of the function of membrane-bound lectins, and development of new strategies for controlling B cell function.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
Hokazono, Y., Adachi, T., Wabl, M., Tada, N., Amagasa, T., Tsubata T.: "Inhibitory co-receptors activated by antigens but not by anti immunoglobulin heavy chain antibodies install requirement of co-stimulation through CD40 for survival and proliferation o
Hokazono,Y.,Adachi,T.,Wabl,M.,Tada,N.,Amagasa,T.,Tsubata T.:“由抗原激活的抑制性共受体,但不由抗免疫球蛋白重链抗体激活,需要共-
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Involvement of cell cycle progression in survaival signaling through CD40 inB lymphocyte line Wehi-231.
通过 B 淋巴细胞系 Wehi-231 中的 CD40 参与细胞周期进程的生存信号传导。
DOI: --
发表时间: 2003
期刊: Cell. Death. Differ 11
影响因子: --
作者: [Hirai H, Adachi T, Tsubata T.]
通讯作者: Tsubata T.
Inhibitory co-receptors activated by antigens but not by anti immunoglobulin heavy chain antibodies install requirement of co-stimulation through CD40 for survival and proliferation of B cells.
由抗原激活但不由抗免疫球蛋白重链抗体激活的抑制性共受体需要通过 CD40 进行共刺激才能使 B 细胞存活和增殖。
DOI: --
发表时间: 2003
期刊: J. Immunol. 171
影响因子: --
作者: [Hokazono, Y., Adachi, T., Wabl, M., Tada, N., Amagasa, T., Tsubata' T.]
通讯作者: Tsubata' T.
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Studies on Siglecs expressed on B lymphocytes and their glycan ligands
  • 批准号:
    26293062
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $10.32万
  • 财政年份:
    2014
  • 负责人:
    TSUBATA Takeshi
  • 依托单位:
Carbohydrate recognition of B lymphocyte lectins and their function
  • 批准号:
    23390063
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $6.32万
  • 财政年份:
    2011
  • 负责人:
    TSUBATA Takeshi
  • 依托单位:
Immunogenetic analysis of the resistance to infectious diseases
  • 批准号:
    18406019
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $6.89万
  • 财政年份:
    2006
  • 负责人:
    TSUBATA Takeshi
  • 依托单位:
Regulation of cell death by cell cycling
  • 批准号:
    13043013
  • 项目类别:
    Grant-in-Aid for Scientific Research on Priority Areas
  • 资助金额:
    $67.97万
  • 财政年份:
    2001
  • 负责人:
    TSUBATA Takeshi
  • 依托单位:
国内基金
海外基金
外周血中B淋巴细胞BCR CDR3分子特征监测在乙型肝炎患者疗效预测中的应用研究
EB病毒蛋白BZLF1上调CD40/CD40L- KU80/RAG信号通路促进BCR二次重排在机 体丧失自身免疫耐受的机制
巴弗洛霉素A1通过抑制Lamp-1介导的BCR信号通路提高淋巴瘤化疗 敏感性的机制研究
TED患者BCR组库的偏倚及TSHR特异性B细胞来源的鉴定